Novadip Biosciences
Philippe Durieux has been a member of the company’s board of directors since 2013. Philippe is CEO of Sopartec, the technology transfer and investment company of the Université Catholique de Louvain and managing director of Vives Funds. He is also a member of the investment committee of SATT Nord. Prior to joining Sopartec, Philippe was senior investment manager at Dexia Private Equity and senior credit manager at WestLB. He holds a graduate degree in economics from University College London and a post-graduate degree in finance from Hautes Etudes Commercials Saint-Louis.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Novadip Biosciences
Novadip is transforming the lives of patients using its unique “3M3” tissue regeneration technology platform.